Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.37270388 |
2 | synaptic vesicle maturation (GO:0016188) | 6.32098879 |
3 | locomotory exploration behavior (GO:0035641) | 6.24018502 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.05099182 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.72983146 |
6 | vocalization behavior (GO:0071625) | 5.53597890 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.46658218 |
8 | synaptic vesicle exocytosis (GO:0016079) | 5.27062576 |
9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.21190495 |
10 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.07625043 |
11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.04313218 |
12 | glutamate secretion (GO:0014047) | 5.01462997 |
13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.97512999 |
14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.93119541 |
15 | exploration behavior (GO:0035640) | 4.81315650 |
16 | cerebellar granule cell differentiation (GO:0021707) | 4.77086131 |
17 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.70676754 |
18 | protein localization to synapse (GO:0035418) | 4.69322364 |
19 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.50526681 |
20 | regulation of synaptic vesicle transport (GO:1902803) | 4.47064188 |
21 | neuronal action potential propagation (GO:0019227) | 4.45585003 |
22 | neurotransmitter secretion (GO:0007269) | 4.44075138 |
23 | synaptic transmission, glutamatergic (GO:0035249) | 4.44051697 |
24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.37896172 |
25 | glutamate receptor signaling pathway (GO:0007215) | 4.34782727 |
26 | L-amino acid import (GO:0043092) | 4.32268162 |
27 | dendritic spine morphogenesis (GO:0060997) | 4.28051397 |
28 | long-term memory (GO:0007616) | 4.26402428 |
29 | potassium ion import (GO:0010107) | 4.23792264 |
30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.23421384 |
31 | layer formation in cerebral cortex (GO:0021819) | 4.21481067 |
32 | potassium ion homeostasis (GO:0055075) | 4.17608312 |
33 | neuron-neuron synaptic transmission (GO:0007270) | 4.13490787 |
34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.11127067 |
35 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.08063766 |
36 | positive regulation of membrane potential (GO:0045838) | 4.05414760 |
37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03611207 |
38 | cellular potassium ion homeostasis (GO:0030007) | 4.01379627 |
39 | neuron cell-cell adhesion (GO:0007158) | 3.98638719 |
40 | * positive regulation of synapse maturation (GO:0090129) | 3.94762285 |
41 | gamma-aminobutyric acid transport (GO:0015812) | 3.94229174 |
42 | central nervous system myelination (GO:0022010) | 3.88622808 |
43 | axon ensheathment in central nervous system (GO:0032291) | 3.88622808 |
44 | * regulation of synapse structural plasticity (GO:0051823) | 3.87518652 |
45 | * regulation of synaptic plasticity (GO:0048167) | 3.78010417 |
46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.77488451 |
47 | amino acid import (GO:0043090) | 3.75442375 |
48 | sodium ion export (GO:0071436) | 3.74749835 |
49 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.72951566 |
50 | activation of protein kinase A activity (GO:0034199) | 3.67148616 |
51 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.62766628 |
52 | transmission of nerve impulse (GO:0019226) | 3.60705502 |
53 | cellular sodium ion homeostasis (GO:0006883) | 3.60523626 |
54 | auditory behavior (GO:0031223) | 3.60400712 |
55 | regulation of cell communication by electrical coupling (GO:0010649) | 3.59330723 |
56 | * neuromuscular process controlling balance (GO:0050885) | 3.58760811 |
57 | proline transport (GO:0015824) | 3.57845848 |
58 | neuromuscular synaptic transmission (GO:0007274) | 3.56767012 |
59 | prepulse inhibition (GO:0060134) | 3.55851092 |
60 | long-term synaptic potentiation (GO:0060291) | 3.53211190 |
61 | * regulation of dendritic spine morphogenesis (GO:0061001) | 3.52096349 |
62 | neurotransmitter transport (GO:0006836) | 3.50719854 |
63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.50489568 |
64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.48461715 |
65 | synaptic vesicle endocytosis (GO:0048488) | 3.45668765 |
66 | behavioral fear response (GO:0001662) | 3.40921963 |
67 | behavioral defense response (GO:0002209) | 3.40921963 |
68 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.40363114 |
69 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.38067614 |
70 | regulation of neurotransmitter secretion (GO:0046928) | 3.37951547 |
71 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.37349605 |
72 | dendritic spine organization (GO:0097061) | 3.36670915 |
73 | * positive regulation of dendritic spine development (GO:0060999) | 3.36006925 |
74 | cell communication by electrical coupling (GO:0010644) | 3.35429952 |
75 | regulation of vesicle fusion (GO:0031338) | 3.34773774 |
76 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.34360931 |
77 | response to auditory stimulus (GO:0010996) | 3.33204545 |
78 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.32944598 |
79 | neuron recognition (GO:0008038) | 3.32422779 |
80 | detection of calcium ion (GO:0005513) | 3.31798465 |
81 | regulation of neurotransmitter levels (GO:0001505) | 3.31355914 |
82 | positive regulation of neurotransmitter transport (GO:0051590) | 3.31193122 |
83 | cell differentiation in hindbrain (GO:0021533) | 3.28164362 |
84 | neuromuscular process controlling posture (GO:0050884) | 3.27916249 |
85 | dendrite morphogenesis (GO:0048813) | 3.27883199 |
86 | neurotransmitter uptake (GO:0001504) | 3.25275041 |
87 | neuronal ion channel clustering (GO:0045161) | 3.24274042 |
88 | membrane depolarization (GO:0051899) | 3.23711581 |
89 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.22763772 |
90 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22159422 |
91 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.21734974 |
92 | glycine transport (GO:0015816) | 3.20325463 |
93 | membrane depolarization during action potential (GO:0086010) | 3.19969748 |
94 | cell communication involved in cardiac conduction (GO:0086065) | 3.19440124 |
95 | learning (GO:0007612) | 3.17996793 |
96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17752457 |
97 | regulation of neurotransmitter transport (GO:0051588) | 3.17466695 |
98 | fear response (GO:0042596) | 3.16481142 |
99 | regulation of ARF protein signal transduction (GO:0032012) | 3.16366692 |
100 | regulation of female receptivity (GO:0045924) | 3.16034645 |
101 | acidic amino acid transport (GO:0015800) | 3.15056520 |
102 | innervation (GO:0060384) | 3.14728478 |
103 | chemosensory behavior (GO:0007635) | 3.14330708 |
104 | vesicle transport along microtubule (GO:0047496) | 3.14327153 |
105 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.12221090 |
106 | postsynaptic membrane organization (GO:0001941) | 3.12128820 |
107 | membrane hyperpolarization (GO:0060081) | 3.09015208 |
108 | positive regulation of synaptic transmission (GO:0050806) | 3.08376319 |
109 | * regulation of synapse maturation (GO:0090128) | 3.08036192 |
110 | serotonin metabolic process (GO:0042428) | 3.05894460 |
111 | axonal fasciculation (GO:0007413) | 3.05489390 |
112 | * regulation of synaptic transmission (GO:0050804) | 3.03044442 |
113 | long term synaptic depression (GO:0060292) | 3.01191572 |
114 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.98744194 |
115 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.98653378 |
116 | response to histamine (GO:0034776) | 2.98633642 |
117 | establishment of synaptic vesicle localization (GO:0097480) | 2.96739153 |
118 | synaptic vesicle transport (GO:0048489) | 2.96739153 |
119 | vesicle docking involved in exocytosis (GO:0006904) | 2.95237034 |
120 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.95002539 |
121 | intraspecies interaction between organisms (GO:0051703) | 2.93809988 |
122 | social behavior (GO:0035176) | 2.93809988 |
123 | * neuromuscular process (GO:0050905) | 2.93683677 |
124 | * synaptic transmission (GO:0007268) | 2.93521691 |
125 | dopamine receptor signaling pathway (GO:0007212) | 2.93519161 |
126 | * regulation of dendritic spine development (GO:0060998) | 2.91647324 |
127 | visual learning (GO:0008542) | 2.91483160 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.06557843 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20629585 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11176477 |
4 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.07114511 |
5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04177708 |
6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02895833 |
7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.86856292 |
8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.80730726 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75571545 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75571545 |
11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68000881 |
12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.59748919 |
13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58859782 |
14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57930485 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47465072 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45173666 |
17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42739985 |
18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.37701915 |
19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.37148191 |
20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.36391283 |
21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31682627 |
22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.30818681 |
23 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20336373 |
24 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.19407814 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15962839 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09106968 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06609642 |
28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03470453 |
29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86161185 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80172496 |
31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69228914 |
32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64992813 |
33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59623487 |
34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50671427 |
35 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45482400 |
36 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43230827 |
37 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.42880187 |
38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39324350 |
39 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33926843 |
40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33350788 |
41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29309274 |
42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27507943 |
43 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26987622 |
44 | * AR_19668381_ChIP-Seq_PC3_Human | 1.24804697 |
45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24377664 |
46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24372947 |
47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24351354 |
48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22616955 |
49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22273512 |
50 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21957189 |
51 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19747254 |
52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18811702 |
53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15594108 |
54 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15170244 |
55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14264961 |
56 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13933122 |
57 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.12409705 |
58 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09436410 |
59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08725627 |
60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08650331 |
61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08499179 |
62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07787911 |
63 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07403432 |
64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07121575 |
65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06934941 |
66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05095023 |
67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04309718 |
68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03493791 |
69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03478179 |
70 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01639066 |
71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01227467 |
72 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.01022609 |
73 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.00732762 |
74 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00134198 |
75 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99934832 |
76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98347669 |
77 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98187615 |
78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97613021 |
79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97505708 |
80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97479779 |
81 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97381745 |
82 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97280698 |
83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96779713 |
84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95937314 |
85 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95641195 |
86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95507250 |
87 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94580007 |
88 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93883435 |
89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93285874 |
90 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93064632 |
91 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92113472 |
92 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92066563 |
93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91017076 |
94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89930122 |
95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89568530 |
96 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89360276 |
97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88791218 |
98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88754810 |
99 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.87237631 |
100 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87047631 |
101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86713857 |
102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85436275 |
103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85378772 |
104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85177774 |
105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85113958 |
106 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.84030044 |
107 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83803335 |
108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83793831 |
109 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81187592 |
110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.80919466 |
111 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.80755187 |
112 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79922492 |
113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79243074 |
114 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.78462402 |
115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78303959 |
116 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77762637 |
117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77720886 |
118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77154587 |
119 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.75677526 |
120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.74358440 |
121 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.73797386 |
122 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.71846698 |
123 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71511626 |
124 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71393622 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0004859_abnormal_synaptic_plasticity | 7.14029292 |
2 | MP0003880_abnormal_central_pattern | 4.62129524 |
3 | * MP0003635_abnormal_synaptic_transmissio | 4.39160100 |
4 | MP0002822_catalepsy | 3.94405291 |
5 | MP0004270_analgesia | 3.80227264 |
6 | MP0009745_abnormal_behavioral_response | 3.58796834 |
7 | MP0002063_abnormal_learning/memory/cond | 3.56505671 |
8 | MP0002064_seizures | 3.21315971 |
9 | MP0009046_muscle_twitch | 2.99499405 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.87149582 |
11 | MP0001968_abnormal_touch/_nociception | 2.75289718 |
12 | MP0005423_abnormal_somatic_nervous | 2.72661508 |
13 | MP0002272_abnormal_nervous_system | 2.59414672 |
14 | MP0001486_abnormal_startle_reflex | 2.56344360 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.51879456 |
16 | MP0001501_abnormal_sleep_pattern | 2.24673616 |
17 | MP0009780_abnormal_chondrocyte_physiolo | 2.23130359 |
18 | MP0002909_abnormal_adrenal_gland | 2.13254492 |
19 | MP0001440_abnormal_grooming_behavior | 2.05826188 |
20 | MP0002735_abnormal_chemical_nociception | 2.05640127 |
21 | MP0002736_abnormal_nociception_after | 2.02452056 |
22 | MP0008569_lethality_at_weaning | 1.99939653 |
23 | MP0002733_abnormal_thermal_nociception | 1.91709353 |
24 | MP0001970_abnormal_pain_threshold | 1.87851579 |
25 | MP0003329_amyloid_beta_deposits | 1.86444742 |
26 | MP0004811_abnormal_neuron_physiology | 1.85171469 |
27 | MP0002067_abnormal_sensory_capabilities | 1.83166210 |
28 | MP0002557_abnormal_social/conspecific_i | 1.76497965 |
29 | MP0004924_abnormal_behavior | 1.73990569 |
30 | MP0005386_behavior/neurological_phenoty | 1.73990569 |
31 | MP0002184_abnormal_innervation | 1.71825612 |
32 | MP0005646_abnormal_pituitary_gland | 1.70340107 |
33 | MP0004858_abnormal_nervous_system | 1.70139705 |
34 | MP0003879_abnormal_hair_cell | 1.65142425 |
35 | MP0000778_abnormal_nervous_system | 1.63467791 |
36 | MP0004885_abnormal_endolymph | 1.58633964 |
37 | MP0000955_abnormal_spinal_cord | 1.55050989 |
38 | MP0001984_abnormal_olfaction | 1.45742796 |
39 | MP0003787_abnormal_imprinting | 1.43042851 |
40 | * MP0002066_abnormal_motor_capabilities/c | 1.41210143 |
41 | MP0003633_abnormal_nervous_system | 1.40157992 |
42 | MP0002882_abnormal_neuron_morphology | 1.37873417 |
43 | MP0003123_paternal_imprinting | 1.24522447 |
44 | MP0001502_abnormal_circadian_rhythm | 1.23530738 |
45 | MP0001529_abnormal_vocalization | 1.23036709 |
46 | MP0005645_abnormal_hypothalamus_physiol | 1.19615011 |
47 | MP0003075_altered_response_to | 1.18800241 |
48 | MP0003631_nervous_system_phenotype | 1.14947525 |
49 | MP0003283_abnormal_digestive_organ | 1.14620574 |
50 | MP0006276_abnormal_autonomic_nervous | 1.14172080 |
51 | MP0004145_abnormal_muscle_electrophysio | 1.10836756 |
52 | MP0002152_abnormal_brain_morphology | 1.08410166 |
53 | MP0004142_abnormal_muscle_tone | 1.08081104 |
54 | MP0001905_abnormal_dopamine_level | 1.05966568 |
55 | MP0000013_abnormal_adipose_tissue | 1.04576048 |
56 | MP0008961_abnormal_basal_metabolism | 1.03870150 |
57 | MP0008872_abnormal_physiological_respon | 1.02451028 |
58 | MP0002069_abnormal_eating/drinking_beha | 0.99732894 |
59 | MP0000751_myopathy | 0.99190402 |
60 | MP0008874_decreased_physiological_sensi | 0.98933375 |
61 | MP0001177_atelectasis | 0.98174906 |
62 | MP0000569_abnormal_digit_pigmentation | 0.94379827 |
63 | MP0001188_hyperpigmentation | 0.93476772 |
64 | MP0001348_abnormal_lacrimal_gland | 0.93398712 |
65 | MP0002229_neurodegeneration | 0.92296869 |
66 | MP0003122_maternal_imprinting | 0.90961648 |
67 | MP0004147_increased_porphyrin_level | 0.89966907 |
68 | MP0005535_abnormal_body_temperature | 0.88329306 |
69 | MP0004085_abnormal_heartbeat | 0.87958584 |
70 | MP0003690_abnormal_glial_cell | 0.85406714 |
71 | MP0005551_abnormal_eye_electrophysiolog | 0.82742746 |
72 | MP0010386_abnormal_urinary_bladder | 0.82722910 |
73 | MP0000604_amyloidosis | 0.81951285 |
74 | MP0008877_abnormal_DNA_methylation | 0.81781396 |
75 | MP0003634_abnormal_glial_cell | 0.79723654 |
76 | MP0003632_abnormal_nervous_system | 0.78907409 |
77 | MP0002090_abnormal_vision | 0.78171080 |
78 | MP0004036_abnormal_muscle_relaxation | 0.77702937 |
79 | MP0004043_abnormal_pH_regulation | 0.76536610 |
80 | MP0005167_abnormal_blood-brain_barrier | 0.76527725 |
81 | MP0010234_abnormal_vibrissa_follicle | 0.74657047 |
82 | MP0000749_muscle_degeneration | 0.74320192 |
83 | MP0005499_abnormal_olfactory_system | 0.73821316 |
84 | MP0005394_taste/olfaction_phenotype | 0.73821316 |
85 | MP0004510_myositis | 0.73103196 |
86 | MP0000920_abnormal_myelination | 0.72791735 |
87 | MP0000747_muscle_weakness | 0.71764711 |
88 | MP0001346_abnormal_lacrimal_gland | 0.71070982 |
89 | MP0000631_abnormal_neuroendocrine_gland | 0.70663218 |
90 | MP0001986_abnormal_taste_sensitivity | 0.69890901 |
91 | MP0003646_muscle_fatigue | 0.69766357 |
92 | MP0005409_darkened_coat_color | 0.69262501 |
93 | MP0004233_abnormal_muscle_weight | 0.68932444 |
94 | MP0004215_abnormal_myocardial_fiber | 0.68156858 |
95 | MP0003137_abnormal_impulse_conducting | 0.67930057 |
96 | MP0001963_abnormal_hearing_physiology | 0.67394136 |
97 | MP0004742_abnormal_vestibular_system | 0.66645118 |
98 | MP0003172_abnormal_lysosome_physiology | 0.64930692 |
99 | MP0002234_abnormal_pharynx_morphology | 0.63360326 |
100 | MP0002752_abnormal_somatic_nervous | 0.62238004 |
101 | MP0002837_dystrophic_cardiac_calcinosis | 0.60939609 |
102 | MP0001664_abnormal_digestion | 0.59359863 |
103 | MP0004484_altered_response_of | 0.58826840 |
104 | MP0005620_abnormal_muscle_contractility | 0.55733291 |
105 | MP0001485_abnormal_pinna_reflex | 0.55339462 |
106 | MP0002638_abnormal_pupillary_reflex | 0.53008456 |
107 | MP0003045_fibrosis | 0.51630818 |
108 | MP0010769_abnormal_survival | 0.51357985 |
109 | MP0000026_abnormal_inner_ear | 0.51251577 |
110 | MP0003956_abnormal_body_size | 0.51220113 |
111 | MP0003861_abnormal_nervous_system | 0.50269885 |
112 | MP0010768_mortality/aging | 0.49536907 |
113 | MP0004130_abnormal_muscle_cell | 0.48724858 |
114 | MP0001943_abnormal_respiration | 0.48575012 |
115 | MP0002106_abnormal_muscle_physiology | 0.47281893 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.75065647 |
2 | Myokymia (HP:0002411) | 7.72970659 |
3 | Focal seizures (HP:0007359) | 5.80862153 |
4 | Visual hallucinations (HP:0002367) | 5.56153801 |
5 | Epileptic encephalopathy (HP:0200134) | 4.59975419 |
6 | Action tremor (HP:0002345) | 4.32397733 |
7 | Progressive cerebellar ataxia (HP:0002073) | 4.29519814 |
8 | Febrile seizures (HP:0002373) | 4.13623090 |
9 | Atonic seizures (HP:0010819) | 4.08404157 |
10 | Absence seizures (HP:0002121) | 3.97808872 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.84195570 |
12 | Poor eye contact (HP:0000817) | 3.74915436 |
13 | Supranuclear gaze palsy (HP:0000605) | 3.68430560 |
14 | Dialeptic seizures (HP:0011146) | 3.68230336 |
15 | Broad-based gait (HP:0002136) | 3.62291079 |
16 | Depression (HP:0000716) | 3.53785028 |
17 | Ankle clonus (HP:0011448) | 3.52601617 |
18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.48638833 |
19 | Gaze-evoked nystagmus (HP:0000640) | 3.42738553 |
20 | Abnormality of the lower motor neuron (HP:0002366) | 3.41894728 |
21 | Impaired social interactions (HP:0000735) | 3.37248159 |
22 | Abnormal social behavior (HP:0012433) | 3.37248159 |
23 | Dysdiadochokinesis (HP:0002075) | 3.35719025 |
24 | Cerebral hypomyelination (HP:0006808) | 3.34849363 |
25 | Anxiety (HP:0000739) | 3.30965972 |
26 | Dysmetria (HP:0001310) | 3.21473842 |
27 | Mutism (HP:0002300) | 3.20473430 |
28 | Papilledema (HP:0001085) | 3.18817635 |
29 | Postural instability (HP:0002172) | 3.12991092 |
30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.06051831 |
31 | Torticollis (HP:0000473) | 3.05064630 |
32 | Truncal ataxia (HP:0002078) | 2.97210301 |
33 | Akinesia (HP:0002304) | 2.95463224 |
34 | Impaired smooth pursuit (HP:0007772) | 2.94829060 |
35 | Abnormal eating behavior (HP:0100738) | 2.88965505 |
36 | Genetic anticipation (HP:0003743) | 2.88111776 |
37 | Focal dystonia (HP:0004373) | 2.84891354 |
38 | Annular pancreas (HP:0001734) | 2.79870432 |
39 | Hyperventilation (HP:0002883) | 2.79221741 |
40 | Amblyopia (HP:0000646) | 2.77149826 |
41 | Intention tremor (HP:0002080) | 2.75111637 |
42 | Hemiparesis (HP:0001269) | 2.73199083 |
43 | Stereotypic behavior (HP:0000733) | 2.72740683 |
44 | Scanning speech (HP:0002168) | 2.71262421 |
45 | Hemiplegia (HP:0002301) | 2.67544552 |
46 | Urinary urgency (HP:0000012) | 2.67046729 |
47 | Drooling (HP:0002307) | 2.63209353 |
48 | Excessive salivation (HP:0003781) | 2.63209353 |
49 | Ventricular fibrillation (HP:0001663) | 2.59912494 |
50 | Dysmetric saccades (HP:0000641) | 2.58470641 |
51 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.57658693 |
52 | Bradykinesia (HP:0002067) | 2.57400023 |
53 | Spastic gait (HP:0002064) | 2.57178108 |
54 | Epileptiform EEG discharges (HP:0011182) | 2.53760046 |
55 | Craniofacial dystonia (HP:0012179) | 2.52717717 |
56 | Neurofibrillary tangles (HP:0002185) | 2.52541741 |
57 | Cerebral inclusion bodies (HP:0100314) | 2.52254833 |
58 | Sleep apnea (HP:0010535) | 2.51104456 |
59 | Megalencephaly (HP:0001355) | 2.50801933 |
60 | Abnormality of binocular vision (HP:0011514) | 2.49947418 |
61 | Diplopia (HP:0000651) | 2.49947418 |
62 | Sudden death (HP:0001699) | 2.46157260 |
63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44590756 |
64 | Pointed chin (HP:0000307) | 2.41963178 |
65 | Heart block (HP:0012722) | 2.38912123 |
66 | Impaired vibratory sensation (HP:0002495) | 2.34233237 |
67 | Hypsarrhythmia (HP:0002521) | 2.33974532 |
68 | Progressive inability to walk (HP:0002505) | 2.30863333 |
69 | Status epilepticus (HP:0002133) | 2.27625914 |
70 | Bundle branch block (HP:0011710) | 2.26727252 |
71 | Syncope (HP:0001279) | 2.24302794 |
72 | Obstructive sleep apnea (HP:0002870) | 2.24078706 |
73 | Hyporeflexia of lower limbs (HP:0002600) | 2.19392674 |
74 | Resting tremor (HP:0002322) | 2.18583811 |
75 | Insomnia (HP:0100785) | 2.18192120 |
76 | Amyotrophic lateral sclerosis (HP:0007354) | 2.15710135 |
77 | Choreoathetosis (HP:0001266) | 2.12883712 |
78 | Abnormal atrioventricular conduction (HP:0005150) | 2.12730668 |
79 | Fetal akinesia sequence (HP:0001989) | 2.11987868 |
80 | Lower limb muscle weakness (HP:0007340) | 2.10481431 |
81 | Ankyloglossia (HP:0010296) | 2.09918272 |
82 | Abnormal EKG (HP:0003115) | 2.09212562 |
83 | Spastic tetraparesis (HP:0001285) | 2.07002627 |
84 | Myotonia (HP:0002486) | 2.06817470 |
85 | Absent speech (HP:0001344) | 2.06407688 |
86 | Generalized myoclonic seizures (HP:0002123) | 2.03827857 |
87 | Clonus (HP:0002169) | 2.03563149 |
88 | Incomplete penetrance (HP:0003829) | 2.02580523 |
89 | Agitation (HP:0000713) | 2.02487089 |
90 | CNS hypomyelination (HP:0003429) | 2.01262453 |
91 | Limb dystonia (HP:0002451) | 1.99892288 |
92 | Spinal canal stenosis (HP:0003416) | 1.99582983 |
93 | Gait ataxia (HP:0002066) | 1.99147028 |
94 | Abnormality of the corticospinal tract (HP:0002492) | 1.98196333 |
95 | Exercise-induced myalgia (HP:0003738) | 1.98058305 |
96 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.97595941 |
97 | Insidious onset (HP:0003587) | 1.96184441 |
98 | Termporal pattern (HP:0011008) | 1.96184441 |
99 | Muscle fiber inclusion bodies (HP:0100299) | 1.94564055 |
100 | Lower limb amyotrophy (HP:0007210) | 1.94544913 |
101 | Polyphagia (HP:0002591) | 1.94004006 |
102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93891458 |
103 | Peripheral hypomyelination (HP:0007182) | 1.92072614 |
104 | Lower limb asymmetry (HP:0100559) | 1.91271805 |
105 | Neuronal loss in central nervous system (HP:0002529) | 1.90984678 |
106 | Rigidity (HP:0002063) | 1.87816051 |
107 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87615912 |
108 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87615912 |
109 | Aplasia involving bones of the extremities (HP:0009825) | 1.87615912 |
110 | Abnormality of saccadic eye movements (HP:0000570) | 1.86376607 |
111 | Exercise-induced muscle cramps (HP:0003710) | 1.85865312 |
112 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.84736213 |
113 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.84736213 |
114 | Unsteady gait (HP:0002317) | 1.84177080 |
115 | Apathy (HP:0000741) | 1.82909567 |
116 | Rapidly progressive (HP:0003678) | 1.81916860 |
117 | Pheochromocytoma (HP:0002666) | 1.81665243 |
118 | Inappropriate behavior (HP:0000719) | 1.80938089 |
119 | Prolonged QT interval (HP:0001657) | 1.80619057 |
120 | Inability to walk (HP:0002540) | 1.79412102 |
121 | Blue irides (HP:0000635) | 1.75171016 |
122 | Tetraplegia (HP:0002445) | 1.75104841 |
123 | Psychosis (HP:0000709) | 1.74553116 |
124 | Delusions (HP:0000746) | 1.73670374 |
125 | Abnormality of the periventricular white matter (HP:0002518) | 1.73369240 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.28402476 |
2 | NTRK3 | 4.80009912 |
3 | MAP3K9 | 4.00293249 |
4 | MARK1 | 3.02622794 |
5 | MINK1 | 2.65105751 |
6 | DAPK2 | 2.64656850 |
7 | MAP3K4 | 2.60274999 |
8 | PRKD3 | 2.56988395 |
9 | KSR2 | 2.49926157 |
10 | PAK6 | 2.33713304 |
11 | CAMKK1 | 2.15743241 |
12 | MAP2K7 | 2.01808061 |
13 | NTRK2 | 1.99179884 |
14 | RIPK4 | 1.85237285 |
15 | KSR1 | 1.77364835 |
16 | NTRK1 | 1.76066762 |
17 | MAP2K4 | 1.64792107 |
18 | CDK5 | 1.61557281 |
19 | DAPK1 | 1.59635386 |
20 | ARAF | 1.52606748 |
21 | MAP3K13 | 1.50966363 |
22 | TNIK | 1.50621952 |
23 | PRPF4B | 1.45811587 |
24 | STK38 | 1.45360747 |
25 | FES | 1.44526447 |
26 | MAP3K2 | 1.38985093 |
27 | MAP3K12 | 1.31136895 |
28 | SIK2 | 1.29674953 |
29 | CAMKK2 | 1.23250444 |
30 | PRKCG | 1.21061731 |
31 | TAOK1 | 1.19766451 |
32 | TYRO3 | 1.18473157 |
33 | MAPK12 | 1.17076792 |
34 | MAPK13 | 1.14889027 |
35 | GRK5 | 1.14723933 |
36 | OBSCN | 1.13949631 |
37 | PLK2 | 1.10682458 |
38 | UHMK1 | 1.06527379 |
39 | CAMK1 | 1.04725736 |
40 | PHKG2 | 1.02809196 |
41 | PHKG1 | 1.02809196 |
42 | RAF1 | 1.00360830 |
43 | PRKCH | 0.96860052 |
44 | CDK19 | 0.96232314 |
45 | CAMK2A | 0.91467684 |
46 | CDK18 | 0.91423302 |
47 | CDK15 | 0.91214012 |
48 | PINK1 | 0.91201901 |
49 | STK11 | 0.90399456 |
50 | PKN1 | 0.89925738 |
51 | PNCK | 0.88069010 |
52 | CDK14 | 0.86066848 |
53 | SGK223 | 0.85512908 |
54 | SGK494 | 0.85512908 |
55 | ALK | 0.85437451 |
56 | CASK | 0.84481704 |
57 | MARK2 | 0.83502414 |
58 | PTK2B | 0.83502110 |
59 | CDK11A | 0.79614396 |
60 | RET | 0.79388600 |
61 | LATS2 | 0.76028737 |
62 | PDK1 | 0.74765429 |
63 | MAP3K1 | 0.74548976 |
64 | LIMK1 | 0.74543901 |
65 | SGK1 | 0.73956607 |
66 | PAK3 | 0.72968328 |
67 | SGK2 | 0.72929888 |
68 | SGK3 | 0.71016388 |
69 | DYRK1A | 0.69340998 |
70 | PDPK1 | 0.68853347 |
71 | MAP3K11 | 0.68743182 |
72 | RIPK1 | 0.68719592 |
73 | BMPR2 | 0.67005421 |
74 | LMTK2 | 0.62324558 |
75 | MAP3K7 | 0.59060402 |
76 | NEK1 | 0.58990245 |
77 | RPS6KA3 | 0.54164741 |
78 | CDC42BPA | 0.53469735 |
79 | PRKCZ | 0.52289251 |
80 | NME1 | 0.52083322 |
81 | MAP2K6 | 0.52015615 |
82 | NEK6 | 0.51399634 |
83 | FGFR2 | 0.50578851 |
84 | CCNB1 | 0.50530490 |
85 | CSNK1G2 | 0.49909069 |
86 | TNK2 | 0.49644190 |
87 | CAMK4 | 0.49635515 |
88 | FYN | 0.48963559 |
89 | * CAMK2B | 0.48493817 |
90 | SCYL2 | 0.46348258 |
91 | DMPK | 0.45817339 |
92 | BRSK1 | 0.44907711 |
93 | FER | 0.44859232 |
94 | MAPK10 | 0.44653515 |
95 | MAP2K1 | 0.44425331 |
96 | CAMK2D | 0.44354139 |
97 | CAMK2G | 0.42106988 |
98 | PRKCE | 0.41063735 |
99 | PRKCA | 0.40829964 |
100 | ROCK1 | 0.40093154 |
101 | OXSR1 | 0.38725185 |
102 | PRKACA | 0.38446889 |
103 | ROCK2 | 0.37909232 |
104 | WNK1 | 0.36234779 |
105 | CAMK1G | 0.36049492 |
106 | PRKG1 | 0.35947917 |
107 | DAPK3 | 0.35306527 |
108 | PRKG2 | 0.35132813 |
109 | PRKD2 | 0.33037930 |
110 | PRKCB | 0.31714459 |
111 | RPS6KA2 | 0.31359680 |
112 | ERBB2 | 0.30677136 |
113 | MAPK4 | 0.30436530 |
114 | MAPK8 | 0.30392558 |
115 | BRAF | 0.29757899 |
116 | WNK3 | 0.29548240 |
117 | FGR | 0.29331074 |
118 | PRKAA1 | 0.29056536 |
119 | MAPKAPK5 | 0.27237409 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.53578459 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12610961 |
3 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.77621907 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.73307921 |
5 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.72364367 |
6 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.72305225 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67541221 |
8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.63988634 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.56116067 |
10 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.48652424 |
11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30779107 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 2.22978702 |
13 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16787662 |
14 | * Insulin secretion_Homo sapiens_hsa04911 | 2.06528440 |
15 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.96658648 |
16 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.91186367 |
17 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.83151174 |
18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.81737355 |
19 | Long-term depression_Homo sapiens_hsa04730 | 1.72911468 |
20 | Renin secretion_Homo sapiens_hsa04924 | 1.71626949 |
21 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.70677147 |
22 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68947094 |
23 | Taste transduction_Homo sapiens_hsa04742 | 1.66667612 |
24 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61450099 |
25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55892861 |
26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.50255609 |
27 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43761771 |
28 | Gap junction_Homo sapiens_hsa04540 | 1.40435256 |
29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38655290 |
30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37184244 |
31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36877735 |
32 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32396733 |
33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29308859 |
34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23857418 |
35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21472639 |
36 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20700318 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18876623 |
38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12263774 |
39 | * Glioma_Homo sapiens_hsa05214 | 1.06444593 |
40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04069904 |
41 | Axon guidance_Homo sapiens_hsa04360 | 1.02001345 |
42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99820860 |
43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97680292 |
44 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96827255 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96652647 |
46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93626488 |
47 | * Melanogenesis_Homo sapiens_hsa04916 | 0.93374497 |
48 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90924500 |
49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89354081 |
50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85907164 |
51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84664462 |
52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82896372 |
53 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.80220996 |
54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79462905 |
55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78968188 |
56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78856496 |
57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76854045 |
58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73025805 |
59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73024320 |
60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72857265 |
61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72379578 |
62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71704480 |
63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70390089 |
64 | Phototransduction_Homo sapiens_hsa04744 | 0.66720860 |
65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66101804 |
66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63708591 |
67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62335305 |
68 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60990847 |
69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60053536 |
70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59583375 |
71 | Bile secretion_Homo sapiens_hsa04976 | 0.59020488 |
72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56480204 |
73 | Alcoholism_Homo sapiens_hsa05034 | 0.56279402 |
74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55987343 |
75 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55490464 |
76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53805914 |
77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53597083 |
78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52861878 |
79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52748751 |
80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52318981 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.52308268 |
82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51967716 |
83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50118853 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49426042 |
85 | Prion diseases_Homo sapiens_hsa05020 | 0.48656858 |
86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46733272 |
87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46217125 |
88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45325547 |
89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45099583 |
90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43728703 |
91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42014158 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.40358301 |
93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40216487 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40090431 |
95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38777054 |
96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37642233 |
97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36716449 |
98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36426166 |
99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34971411 |
100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34259317 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33300892 |
102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32427089 |
103 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30797063 |
104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29684520 |
105 | * Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29551059 |
106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28978350 |
107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28252737 |
108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27507521 |
109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27087649 |
110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26399990 |
111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25727942 |
112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25613336 |
113 | Platelet activation_Homo sapiens_hsa04611 | 0.25404729 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23366573 |